Ten updated NCCN Guidelines: China Editions for Breast, Cervical, Colon, Gastric, Kidney, Non-Small Cell Lung, Ovarian, Pancreatic, and Rectal Cancers, and Multiple Myeloma are now available on-line at NCCNChina.org. Asian oncologists collaborated with NCCN experts to develop the guidelines modified for the Chinese population.
FORT WASHINGTON, Pa.--(BUSINESS WIRE)-- As part of an ongoing effort to address increasing cancer rates in China, Asian oncologists have adopted evidence-based treatment guidelines in collaboration with the National Comprehensive Cancer Network® (NCCN®). A set of 10 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™): China Editions are now available on-line at NCCNChina.org, enabling NCCN information to improve the effectiveness of treatment for a broader population of patients with cancer. Updated 2011 NCCN Guidelines™: China Editions are available for Breast, Cervical, Colon, Gastric, Kidney, Non-Small Cell Lung, Ovarian, Pancreatic, and Rectal Cancers, and Multiple Myeloma.
“This collaboration demonstrates our common goal of sharing resources and increasing familiarity and understanding of the NCCN Guidelines among Asian oncologists,” said William T. McGivney, PhD, CEO of NCCN. “It is critical that evidence-based guidelines for cancer care be implemented by experts across the globe in order to improve outcomes for all patients, regardless of where they live.”
Based on the NCCN Guidelines, the China Editions comprise the extensive expertise of more than 100 Chinese cancer specialists in collaboration with NCCN Guidelines Panel experts. The China Editions contain recommendations revised to account for genetic, pharmacological, and regulatory considerations of the Chinese population.
China has had a long-standing collaboration with NCCN in the development of the Chinese Editions of the NCCN Guidelines - the most authoritative reference for oncology practice in China. Expert clinicians across Asia recognize and routinely apply the NCCN Guidelines in practice. Of the 1.1 million unique visitors to NCCN.org every year, nearly 300,000 are from Asian countries.
NCCN’s international collaborations continue to grow fostered by the demand for the development and publication of foreign editions of the NCCN Guidelines. To view the NCCN Guidelines: China Editions or additional information about NCCN global programs, visit NCCN.org/international.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
Megan Martin, 215-690-0576
KEYWORDS: United States Asia Pacific North America China Pennsylvania
INDUSTRY KEYWORDS: Health Public Policy/Government Oncology Other Policy Issues Public Policy Research Science Managed Care